ElMinda Ltd - Product Pipeline Analysis, 2019 Update
- GDME35860PD
- Pages: 30
- August 2019
- Total Views:1147
- Region : Middle East
- GlobalData
- Equity Research Report
Details
Summary
ElMinda Ltd (ElMinda) is a medical technology company that develops tools for the diagnosis, monitoring, and treatment of brain-related disorders. The company offers brain network activation technology that combines electroencephalography and event-related potential testing procedures with machine-learning and advanced algorithms, and large-population databases to provide a way to see how the brain's neural networks are activated and extract unique data about brain function and health. Its technology is used in various areas, including mild traumatic brain injury, traumatic brain injury, major depressive disorder, Parkinson's disease, multiple sclerosis, ADHD, and mild cognitive impairment. The company has operations in Israel and the US. ElMinda is headquartered in Herzliya, Israel.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ElMinda Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Scope
Table of Contents
Table of Contents
List of Tables
List of Figures
ElMinda Ltd Company Overview
ElMinda Ltd Company Snapshot
ElMinda Ltd Pipeline Products and Ongoing Clinical Trials Overview
ElMinda Ltd-Pipeline Analysis Overview
ElMinda Ltd-Key Facts
ElMinda Ltd-Major Products and Services
ElMinda Ltd Pipeline Products by Development Stage
ElMinda Ltd Ongoing Clinical Trials by Trial Status
ElMinda Ltd Pipeline Products Overview
BNA Analysis System-ADHD
BNA Analysis System-ADHD Product Overview
BNA Analysis System-Mood Disorder
BNA Analysis System-Mood Disorder Product Overview
BNA Analysis System-Mood Disorder Clinical Trial
BNA Analysis System-Pain
BNA Analysis System-Pain Product Overview
BNA Platform-Alzheimer's Disease
BNA Platform-Alzheimer's Disease Product Overview
BNA Platform-Migraine
BNA Platform-Migraine Product Overview
BNA Platform-Parkinson's Disease
BNA Platform-Parkinson's Disease Product Overview
ElMinda Ltd-Key Competitors
ElMinda Ltd-Key Employees
ElMinda Ltd-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ElMinda Ltd, Recent Developments
Mar 05, 2019: European Commission backs elminda's breakthrough in Depression treatment
Apr 15, 2018: elminda presented and demoed at CMEF, the leading health conference in China
Mar 20, 2018: Brain Healthcare Innovator ElMindA Adopting Smart Data
Jun 03, 2016: Study Utilizing ElMindA's BNA Awarded the International Clinical Scholar Award at American College of Sports Medicine Annual Meeting
Mar 02, 2016: ElMindA to Present at the Eleventh World Congress on Brain Injury: BNA As a Physiological Marker for Sports-Related Concussion
Apr 12, 2015: ElMindA Announces approval of BNA Analysis System by the Israeli Ministry of Health
Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System
Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Figure
List of Figures
ElMinda Ltd Pipeline Products by Equipment Type
ElMinda Ltd Pipeline Products by Development Stage
ElMinda Ltd Ongoing Clinical Trials by Trial Status
List Of Table
List of Tables
ElMinda Ltd Pipeline Products and Ongoing Clinical Trials Overview
ElMinda Ltd Pipeline Products by Equipment Type
ElMinda Ltd Pipeline Products by Indication
ElMinda Ltd Ongoing Clinical Trials by Trial Status
ElMinda Ltd, Key Facts
ElMinda Ltd, Major Products and Services
ElMinda Ltd Number of Pipeline Products by Development Stage
ElMinda Ltd Pipeline Products Summary by Development Stage
ElMinda Ltd Ongoing Clinical Trials by Trial Status
ElMinda Ltd Ongoing Clinical Trials Summary
BNA Analysis System-ADHD-Product Status
BNA Analysis System-ADHD-Product Description
BNA Analysis System-Mood Disorder-Product Status
BNA Analysis System-Mood Disorder-Product Description
BNA Analysis System-Mood Disorder-A Combination of Innovative Technologies: EEG, Eye Tracking Device and fMRI in Order to Predict the Success of SSRI Treatment in Patients with Major Depression
BNA Analysis System-Pain-Product Status
BNA Analysis System-Pain-Product Description
BNA Platform-Alzheimer's Disease-Product Status
BNA Platform-Alzheimer's Disease-Product Description
BNA Platform-Migraine-Product Status
BNA Platform-Migraine-Product Description
BNA Platform-Parkinson's Disease-Product Status
BNA Platform-Parkinson's Disease-Product Description
ElMinda Ltd, Key Employees
ElMinda Ltd, Other Locations
Glossary
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
ElMinda Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Neurosonix Ltd.
Perflow Medical, Ltd.
BrainsGate Ltd
Company Profile
Company Profile Title
Summary
ElMinda Ltd (ElMinda) is a medical technology company that develops tools for the diagnosis, monitoring, and treatment of brain-related disorders. The company offers brain network activation technology that combines electroencephalography and event-related potential testing procedures with machine-learning and advanced algorithms, and large-population databases to provide a way to see how the brain's neural networks are activated and extract unique data about brain function and health. Its technology is used in various areas, including mild traumatic brain injury, traumatic brain injury, major depressive disorder, Parkinson's disease, multiple sclerosis, ADHD, and mild cognitive impairment. The company has operations in Israel and the US. ElMinda is headquartered in Herzliya, Israel.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ElMinda Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Scope
Table of Contents
Table of Contents
List of Tables
List of Figures
ElMinda Ltd Company Overview
ElMinda Ltd Company Snapshot
ElMinda Ltd Pipeline Products and Ongoing Clinical Trials Overview
ElMinda Ltd-Pipeline Analysis Overview
ElMinda Ltd-Key Facts
ElMinda Ltd-Major Products and Services
ElMinda Ltd Pipeline Products by Development Stage
ElMinda Ltd Ongoing Clinical Trials by Trial Status
ElMinda Ltd Pipeline Products Overview
BNA Analysis System-ADHD
BNA Analysis System-ADHD Product Overview
BNA Analysis System-Mood Disorder
BNA Analysis System-Mood Disorder Product Overview
BNA Analysis System-Mood Disorder Clinical Trial
BNA Analysis System-Pain
BNA Analysis System-Pain Product Overview
BNA Platform-Alzheimer's Disease
BNA Platform-Alzheimer's Disease Product Overview
BNA Platform-Migraine
BNA Platform-Migraine Product Overview
BNA Platform-Parkinson's Disease
BNA Platform-Parkinson's Disease Product Overview
ElMinda Ltd-Key Competitors
ElMinda Ltd-Key Employees
ElMinda Ltd-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ElMinda Ltd, Recent Developments
Mar 05, 2019: European Commission backs elminda's breakthrough in Depression treatment
Apr 15, 2018: elminda presented and demoed at CMEF, the leading health conference in China
Mar 20, 2018: Brain Healthcare Innovator ElMindA Adopting Smart Data
Jun 03, 2016: Study Utilizing ElMindA's BNA Awarded the International Clinical Scholar Award at American College of Sports Medicine Annual Meeting
Mar 02, 2016: ElMindA to Present at the Eleventh World Congress on Brain Injury: BNA As a Physiological Marker for Sports-Related Concussion
Apr 12, 2015: ElMindA Announces approval of BNA Analysis System by the Israeli Ministry of Health
Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System
Aug 04, 2014: ElMindA Announces FDA Clearance of BNA Analysis System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Figure
List of Figures
ElMinda Ltd Pipeline Products by Equipment Type
ElMinda Ltd Pipeline Products by Development Stage
ElMinda Ltd Ongoing Clinical Trials by Trial Status
List Of Table
List of Tables
ElMinda Ltd Pipeline Products and Ongoing Clinical Trials Overview
ElMinda Ltd Pipeline Products by Equipment Type
ElMinda Ltd Pipeline Products by Indication
ElMinda Ltd Ongoing Clinical Trials by Trial Status
ElMinda Ltd, Key Facts
ElMinda Ltd, Major Products and Services
ElMinda Ltd Number of Pipeline Products by Development Stage
ElMinda Ltd Pipeline Products Summary by Development Stage
ElMinda Ltd Ongoing Clinical Trials by Trial Status
ElMinda Ltd Ongoing Clinical Trials Summary
BNA Analysis System-ADHD-Product Status
BNA Analysis System-ADHD-Product Description
BNA Analysis System-Mood Disorder-Product Status
BNA Analysis System-Mood Disorder-Product Description
BNA Analysis System-Mood Disorder-A Combination of Innovative Technologies: EEG, Eye Tracking Device and fMRI in Order to Predict the Success of SSRI Treatment in Patients with Major Depression
BNA Analysis System-Pain-Product Status
BNA Analysis System-Pain-Product Description
BNA Platform-Alzheimer's Disease-Product Status
BNA Platform-Alzheimer's Disease-Product Description
BNA Platform-Migraine-Product Status
BNA Platform-Migraine-Product Description
BNA Platform-Parkinson's Disease-Product Status
BNA Platform-Parkinson's Disease-Product Description
ElMinda Ltd, Key Employees
ElMinda Ltd, Other Locations
Glossary
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
ElMinda Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Neurosonix Ltd.
Perflow Medical, Ltd.
BrainsGate Ltd
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 179 | 
February 2020
Page 116 | January 2020
Page 235 | January 2020
Page 183 | September 2019
Page 244 | August 2019